PATH EX, Inc.
PrivateLast Round
Series A
Apr 25, 2025
Total Funding Raised
$6.88M
Company Overview
PATH EX, Inc. operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Series A round in April 2025.
PATH EX, Inc. is a medical device company developing CycloPE®, a blood purification device designed to directly capture and remove bacteria from the bloodstream to treat sepsis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PATH EX, Inc. Comparables
Compare PATH EX, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BOA Biomedical Inc. | 88% | |
| Hemotune AG | 84% | |
| Cala Medical | 84% |
For institutional investors. Book with your work email.
PATH EX, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 25, 2025 | ||||
| Grant | Sep 23, 2021 | ||||
| Seed | Oct 1, 2020 | ||||
| Grant | Jun 1, 2018 | ||||
| Grant | Jul 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PATH EX, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Grant |
| IAG Capital Partners | Series A |
| ZeroTo510 | Accelerator |
| MassChallenge Israel | Seed |
| Texas Medical Center | Series A |
| AdvaMed Accel | Grant |
| Fitz Gate Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 152% MoM, reaching 1K.
- Jun 1, 2018
Received $910K from the National Science Foundation.
For institutional investors. Book with your work email.
PATH EX, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PATH EX, Inc.'s valuation, stock price, and market status.
Is PATH EX, Inc. a public or private company?
PATH EX, Inc. is a private company.
What is the current stock price of PATH EX, Inc.?
PATH EX, Inc. is a private company, so its shares have no public market price. Caplight tracks PATH EX, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PATH EX, Inc. worth (valuation)?
Valuation information for PATH EX, Inc. is not publicly available.
Can I buy PATH EX, Inc. stock?
PATH EX, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PATH EX, Inc.'s last funding round?
PATH EX, Inc.'s most recent funding round was Series A on April 25, 2025.
Who are the main investors in PATH EX, Inc.?
Key investors in PATH EX, Inc. include IAG Capital Partners.
Will PATH EX, Inc. IPO soon?
No public IPO plans have been announced for PATH EX, Inc..
How can I track PATH EX, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in PATH EX, Inc.'s shares on secondary markets.